State of Alaska Department of Revenue’s Tvardi Therapeutics TVRD Stock Holding History

State of Alaska Department of Revenue’s Portfolio TVRD Stock Details TVRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-859	Closed	-$151K	–	1646
2023 Q1	$151K	Sell	859 -14	-2%	-$4.69K	﹤0.01%	1610
2022 Q4	$337K	Buy	873 +5	+0.6%	+$1.9K	﹤0.01%	1511
2022 Q3	$292K	Sell	868 -21	-2%	-$7.61K	﹤0.01%	1525
2022 Q2	$292K	Buy	889 +80	+10%	+$28.1K	﹤0.01%	1538
2022 Q1	$353K	Sell	809 -22	-3%	-$9.03K	﹤0.01%	1516
2021 Q4	$364K	Sell	831 -22	-3%	-$11.1K	﹤0.01%	1553
2021 Q3	$474K	Buy	853 +26	+3%	+$13K	﹤0.01%	1483
2021 Q2	$424K	Buy	+827	New	+$524K	﹤0.01%	1502

Other funds holding TVRD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State of Alaska Department of Revenue's TVRD Position: Q2 2023 in Review

State of Alaska Department of Revenue sold out of Tvardi Therapeutics (TVRD) in Q2 2023, closing a stake of 859 shares — an estimated $151K sold.

State of Alaska Department of Revenue first reported a position in TVRD in Q2 2021 and held it in 8 quarters. The position peaked at $474K in Q3 2021. 137 funds tracked by Wall St. Rank hold TVRD as of Q2 2023.

State of Alaska Department of Revenue reported no remaining Tvardi Therapeutics position as of Q2 2023 after selling out during the quarter.
State of Alaska Department of Revenue sold 859 Tvardi Therapeutics shares in Q2 2023, an estimated $151K.
State of Alaska Department of Revenue first reported a position in Tvardi Therapeutics in Q2 2021 and held it in 8 quarters.
State of Alaska Department of Revenue's Tvardi Therapeutics position peaked at $474K in Q3 2021.
137 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2023.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2023, filed 25 Jul 2023.